4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

CUSIP: 35104E100

Q3 2022 13F Holders as of 30 Sep 2022

Security identity
Security type / class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
51,571,939
Holder snapshot
Total 13F shares
26,181,987
Share change
+143,564
Total reported value
$210,496,945
Reported price per share
$8.04
Number of holders
84
Value change
+$1,974,268
Number of buys
39
Number of sells
42

Security key

35104E100

Report period

Q3 2022

Institutions

84

Top holders

10

FDMT full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2022 Previous quarter: Q2 2022 4D Molecular Therapeutics, Inc. SEC filings 4D Molecular Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BVF INC/IL
13D/G signal
—
Evidence rows
15
Latest as of
30 Jun 2022
13F Lead comparable stake: 7.8% Showing 1-6 of 15 holder rows.

Rank 1 holder

BVF INC/IL

13F
Ownership
7.8%
Position
$27.97M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
7.8%
$27,972,000
4,007,413 shares
 — 30 Jun 2022
VIKING GLOBAL INVESTORS LP
13F
Company
13F
7.6%
$27,487,000
3,937,914 shares
 — 30 Jun 2022
Deep Track Capital, LP
13F
Company
13F
6.1%
$21,917,000
3,140,000 shares
 — 30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
4.2%
$15,236,000
2,182,758 shares
 — 30 Jun 2022
ArrowMark Colorado Holdings LLC
13F
Company
13F
2.8%
$9,942,000
1,424,314 shares
 — 30 Jun 2022
JANUS HENDERSON GROUP PLC
13F
Company
13F
2.6%
$9,318,000
1,335,048 shares
 — 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
84
Shares
26,181,987
Rows available
84
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
86
Q3 2022 holders
84
Holder diff
-2
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .